MX2024013169A - Mejoras de seguridad y precision para la edicion de genes inducidos por crispr-cas mediante variantes de adn polimerasa utilizando variantes cas-plus - Google Patents

Mejoras de seguridad y precision para la edicion de genes inducidos por crispr-cas mediante variantes de adn polimerasa utilizando variantes cas-plus

Info

Publication number
MX2024013169A
MX2024013169A MX2024013169A MX2024013169A MX2024013169A MX 2024013169 A MX2024013169 A MX 2024013169A MX 2024013169 A MX2024013169 A MX 2024013169A MX 2024013169 A MX2024013169 A MX 2024013169A MX 2024013169 A MX2024013169 A MX 2024013169A
Authority
MX
Mexico
Prior art keywords
cas
variants
dna polymerase
crispr
enhancement
Prior art date
Application number
MX2024013169A
Other languages
English (en)
Inventor
Chengzu Long
Qiaoyan Yang
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Publication of MX2024013169A publication Critical patent/MX2024013169A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C12N9/222—Clustered regularly interspaced short palindromic repeats [CRISPR]-associated [CAS] enzymes
    • C12N9/226—Class 2 CAS enzyme complex, e.g. single CAS protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/18011—Details ssRNA Bacteriophages positive-sense
    • C12N2795/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07007—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se proporcionan composiciones y métodos que incluyen una ADN polimerasa diseñada utilizada en combinación con una proteína Cas9. La combinación exhibe alteraciones cromosómicas mejoradas en el objetivo, aumenta la proporción de inserciones precisas de 1 a 3 pares de bases en los sitios objetivo y reduce las translocaciones causadas por sistemas previamente disponibles.
MX2024013169A 2022-04-27 2024-10-24 Mejoras de seguridad y precision para la edicion de genes inducidos por crispr-cas mediante variantes de adn polimerasa utilizando variantes cas-plus MX2024013169A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263335625P 2022-04-27 2022-04-27
US202263433353P 2022-12-16 2022-12-16
PCT/US2023/066316 WO2023212657A2 (en) 2022-04-27 2023-04-27 Enhancement of safety and precision for crispr-cas induced gene editing by variants of dna polymerase using cas-plus variants

Publications (1)

Publication Number Publication Date
MX2024013169A true MX2024013169A (es) 2025-04-02

Family

ID=88512711

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024013169A MX2024013169A (es) 2022-04-27 2024-10-24 Mejoras de seguridad y precision para la edicion de genes inducidos por crispr-cas mediante variantes de adn polimerasa utilizando variantes cas-plus

Country Status (9)

Country Link
US (1) US20230348878A1 (es)
EP (1) EP4514963A2 (es)
JP (1) JP2025515471A (es)
KR (1) KR20250005273A (es)
CN (1) CN119173627A (es)
AU (1) AU2023262588A1 (es)
CA (1) CA3250173A1 (es)
MX (1) MX2024013169A (es)
WO (1) WO2023212657A2 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997039150A1 (en) * 1996-04-15 1997-10-23 University Of Southern California Synthesis of fluorophore-labeled dna
CN106987571B (zh) * 2017-05-16 2026-02-03 上海交通大学 一种Cas9核酸酶F916P及其用途
CN113544266A (zh) * 2018-12-17 2021-10-22 博德研究所 Crispr相关转座酶系统和其使用方法
EP4133069A2 (en) * 2020-04-08 2023-02-15 Astrazeneca AB Compositions and methods for improved site-specific modification

Also Published As

Publication number Publication date
KR20250005273A (ko) 2025-01-09
WO2023212657A3 (en) 2023-12-07
CN119173627A (zh) 2024-12-20
EP4514963A2 (en) 2025-03-05
AU2023262588A1 (en) 2024-11-14
CA3250173A1 (en) 2023-11-02
JP2025515471A (ja) 2025-05-15
WO2023212657A2 (en) 2023-11-02
US20230348878A1 (en) 2023-11-02

Similar Documents

Publication Publication Date Title
EP4445902A3 (en) Diacylglycerol kinase modulating compounds
PA8596001A1 (es) Inhibidores de la arn polimerasa dependiente de arn del virus de la hepatitis c y composiciones y tratamientos que los usan
MX2020013347A (es) Polimerasas, composiciones y metodos de uso.
MX2022003414A (es) Celulas efectoras con multiples objetivos y uso de las mismas.
DOP2024000208A (es) Compuestos de modulación de kras g12d
MY204767A (en) Polymerases, compositions, and methods of use
CL2023000554A1 (es) Proteínas diseñadas y métodos de uso de las mismas.
BR112023015937A2 (pt) Compostos, composições e métodos de uso dos mesmos
MX2022001562A (es) Formas solidas de un inhibidor de la cinasa 1 del progenitor hematopoyetico (hpk1).
BR112022004424A2 (pt) Pró-fármacos antivirais e formulações dos mesmos
CR20200553A (es) Moduladores de enzimas modificadoras de metilo, composiciones y usos de estos
SV2007002202A (es) Inhibidores de la arn polimerasa dependiente de arn del virus de la hepatitis c y composiciones y tratamientos que los usan ref. pc32310a
CL2020001349A1 (es) Compuestos, composición y uso de los mismos como moduladores de la expresión de pcsk9. (divisional solicitud 201902574)
MX2019002725A (es) Variantes de endonucleasas de asentamiento pd-1, composiciones y metodos de uso.
DE60222302D1 (de) Inhibitoren von mitotischem kinesin
CL2023003751A1 (es) Compuestos moduladores de diacilglicerol quinasa
MX2017016688A (es) Nuevas enzimas y sistemas crispr.
ATE356804T1 (de) Inhibitoren von mitotischem kinesin
MX2021001578A (es) Proteina asociada a crispr novedosa y uso de la misma.
MX2021012507A (es) Metodos para tratar linfoma no hodgkin con el uso de 2-(2,6-dioxopiperidin-3-il)-4-((2-fluoro-4-((3-morfolinoazetidin- 1-il)metil)bencil)amino)isoindolin-1,3-diona.
MX2021014528A (es) Metodos y composiciones para generar alelos dominantes usando edicion del genoma.
BR112022015380A2 (pt) Composições e métodos para edição de gene de calicreína (klkb1)
MX2021013698A (es) Composiciones y metodos para el tratamiento de la infeccion por virus de la hepatitis b (vhb).
CL2024000858A1 (es) Composiciones de agentes de arni de proteína tau asociada a microtúbulos (mapt)
BR112022014634A2 (pt) Composição, e, processo para produzir a composição